 this patient was found to be biphasic with an initial distribution phase occurring between 0 and 30 minutes after the end of the infusion. The new method is 50 fold more sensitive than the HPLC-UV method and permits direct on-column injection of plasma samples without extraction. Continued clinical studies of BCNU pharmacokinetics in
this patient was found to be biphasic with an initial distribution phase occurring between 0 and 30 minutes after the goal of the infusion. The newfangled method is 50 fold more sensitive than the HPLC - ultraviolet method and permits direct on - column injection of plasma sample without extraction. Continued clinical study of BCNU pharmacokinetics in
 thls patient was found to ne biphasic with an inivial diatributiun phase occurring between 0 end 30 minuuvs after the end of tfe infusiln. The nww mtthod is 50 fold mocs sensibnve tgwn tke HPLC-UV method and permids direct on-conuon injection of plasma samples withoue extravtlon. Continued slinpcwl sfldles of BCNU pharmacokinetics in
this patient was found to be biphasic initial phase occurring 0 and 30 the The new method 50 fold more than the HPLC-UV method and permits on-column injection of plasma samples without extraction. Continued clinical studies of BCNU pharmacokinetics
 this patient was found to be biPhasic with An iniTiaL diStRibuTion Phase occurring BEtweEn 0 and 30 minutes after the enD of thE iNFusiON. THe new Method iS 50 FoLD MorE sEnSitIvE ThAn the hPLc-UV methOd and permiTs dIrEct on-column iNJeCtion of plaSma Samples withoUt eXtractIoN. CoNTinueD clInicaL studiES of BCNu pharmacoKiNEtics iN
 this patient was found to  be biphas ic wi thanin itia l di stribution pha s e oc curring between 0 and30 mi nu t es a f te r the  end of th e inf us io n.Th e  n ew me tho d is 50  fold more  se ns itive than t h eHPLC-UV me tho d and permit s d irecton -co l umn i nje ction  of pl a sma sa mples wit ho u t extr a ction.C o nt inue d clinical studie s  o f  BCNU pharmaco kineti cs in 
 this_patient was_found to be biphasic_with an_initial_distribution phase_occurring_between 0 and_30 minutes after_the end of the_infusion. The new_method_is 50 fold more sensitive than the HPLC-UV method and permits direct on-column injection_of_plasma samples_without_extraction._Continued clinical studies of BCNU_pharmacokinetics in